Pasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community setting Data show low rates of treatment-related adverse ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic ...
AI is becoming crucial in prostate cancer care, improving diagnosis and treatment stratification through enhanced imaging and risk assessment. AI-generated cancer mapping has shown superior accuracy ...
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. PSA is one of the most widely used and ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Patients with metastatic castration-resistant prostate cancer who received Lu-177-PSMA-617 (Pluvicto) achieved similar overall survival and had fewer serious adverse events compared to those who ...
For men, taking care of the prostate is of paramount importance. It is a gland that you may not think of often, particularly if you're young. However, the prostate's location in the body -- below the ...
Please provide your email address to receive an email when new articles are posted on . A diet with reduced omega-6 and increased omega-3 fatty acids could slow progression of prostate cancer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback